{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:05:25Z","timestamp":1788015925652,"version":"build-2784847793"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00296-022-05149-6","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T08:02:45Z","timestamp":1654329765000},"page":"1629-1641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-6549","authenticated-orcid":false,"given":"Daniel","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-8816","authenticated-orcid":false,"given":"Vijaya","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-1894","authenticated-orcid":false,"given":"Emilio B.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-9219","authenticated-orcid":false,"given":"Katrina A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-898X","authenticated-orcid":false,"given":"Ashima","family":"Makol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-5385","authenticated-orcid":false,"given":"Chou Luan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-3870","authenticated-orcid":false,"given":"Farah Nadiah","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4260-8498","authenticated-orcid":false,"given":"Nor Shuhaila","family":"Shahril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-8287","authenticated-orcid":false,"given":"Liza Mohd","family":"Isa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-1269","authenticated-orcid":false,"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-8038","authenticated-orcid":false,"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,4]]},"reference":[{"key":"5149_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02415-20","author":"A Rebendenne","year":"2021","unstructured":"Rebendenne A et al (2021) SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol. https:\/\/doi.org\/10.1128\/jvi.02415-20","journal-title":"J Virol"},{"issue":"2","key":"5149_CR2","doi-asserted-by":"publisher","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","volume":"34","author":"X Yin","year":"2021","unstructured":"Yin X et al (2021) MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep 34(2):108628. https:\/\/doi.org\/10.1016\/j.celrep.2020.108628","journal-title":"Cell Rep"},{"key":"5149_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies (in eng). Front Immunol 12:773352. https:\/\/doi.org\/10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"},{"key":"5149_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218594","author":"Y Wang","year":"2020","unstructured":"Wang Y, Du G, Zhang G, Matucci-Cerinic M, Furst DE (2020) Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future, (in eng). Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218594","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5149_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis (in eng). Clin Rev Allergy Immunol 60(2):293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"5149_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/imj.14789","volume":"50","author":"R Gupta","year":"2020","unstructured":"Gupta R, Kumar S, Gow P, Hsien-Cheng Chang L, Yen L (2020) Anti-MDA5-associated dermatomyositis (in eng). Intern Med J 50(4):484\u2013487. https:\/\/doi.org\/10.1111\/imj.14789","journal-title":"Intern Med J"},{"key":"5149_CR7","doi-asserted-by":"publisher","first-page":"2024869","DOI":"10.1155\/2020\/2024869","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020) Predictors of poor outcome of Anti-MDA5-associated rapidly progressive interstitial lung disease in a Chinese cohort with dermatomyositis (in eng). J Immunol Res 2020:2024869. https:\/\/doi.org\/10.1155\/2020\/2024869","journal-title":"J Immunol Res"},{"issue":"11","key":"5149_CR8","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","volume":"39","author":"K Huang","year":"2019","unstructured":"Huang K et al (2019) Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review (in eng). Rheumatol Int 39(11):1971\u20131981. https:\/\/doi.org\/10.1007\/s00296-019-04398-2","journal-title":"Rheumatol Int"},{"key":"5149_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.646","author":"L Carrasco","year":"2021","unstructured":"Carrasco L, Arthur A, Gaitan Rueda J, Case C (2021) A rapidly progressive and rare illness: autoantibodies against melanoma differentiation-associated protein 5 (anti-MDA5): amyopathic dermatomyositis with progressive interstitial lung disease that developed after covid-19 vaccine. Chest J. https:\/\/doi.org\/10.1016\/j.chest.2021.07.646","journal-title":"Chest J"},{"issue":"1","key":"5149_CR10","doi-asserted-by":"publisher","first-page":"rkx003","DOI":"10.1093\/rap\/rkx003","volume":"1","author":"OS Kotsiou","year":"2017","unstructured":"Kotsiou OS, Daniil Z, Gourgoulianis KI (2017) Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis. Rheumatol Adv Pract 1(1):rkx003. https:\/\/doi.org\/10.1093\/rap\/rkx003","journal-title":"Rheumatol Adv Pract"},{"key":"5149_CR11","doi-asserted-by":"publisher","unstructured":"McNamara L, Brady VA (2021) Is COVID-19 the culprit? A case of anti-MDA5 antibody positivity in a rapidly progressive organizing pneumonia. In: TP31. TP031 INTERESTING CASES ASSOCIATED WITH SARS-COV-2 INFECTION, (American Thoracic Society International Conference Abstracts: American Thoracic Society, pp A2002-A2002. DOI: https:\/\/doi.org\/10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A2002","DOI":"10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A2002"},{"issue":"8","key":"5149_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11926-021-01023-9","volume":"23","author":"A Saud","year":"2021","unstructured":"Saud A, Naveen R, Aggarwal R, Gupta L (2021) COVID-19 and myositis: what we know so far (in eng). Curr Rheumatol Rep 23(8):63. https:\/\/doi.org\/10.1007\/s11926-021-01023-9","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"5149_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","volume":"41","author":"P Mehta","year":"2021","unstructured":"Mehta P, Machado PM, Gupta L (2021) Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry (in eng). Rheumatol Int 41(6):1021\u20131036. https:\/\/doi.org\/10.1007\/s00296-021-04819-1","journal-title":"Rheumatol Int"},{"key":"5149_CR14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01618-2020","author":"M Giannini","year":"2020","unstructured":"Giannini M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A (2020) Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01618-2020","journal-title":"Eur Respir J"},{"issue":"11","key":"5149_CR15","first-page":"20","volume":"68","author":"Y Gokhale","year":"2020","unstructured":"Gokhale Y et al (2020) Dermatomyositis during COVID-19 pandemic (a case series): is there a cause effect relationship? (in eng). J Assoc Phys India 68(11):20\u201324","journal-title":"J Assoc Phys India"},{"issue":"11","key":"5149_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors (in eng). Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"7","key":"5149_CR17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Kuwana M (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease (in eng). Arthritis Rheum 60(7):2193\u20132200. https:\/\/doi.org\/10.1002\/art.24621","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5149_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2169\/internalmedicine.1516-18","volume":"58","author":"N Sakamoto","year":"2019","unstructured":"Sakamoto N et al (2019) Clinical features of Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease without signs of dermatomyositis (in eng). Intern Med 58(6):837\u2013841. https:\/\/doi.org\/10.2169\/internalmedicine.1516-18","journal-title":"Intern Med"},{"issue":"3","key":"5149_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis (in eng). Arthritis Rheumatol 72(3):488\u2013498. https:\/\/doi.org\/10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"5149_CR20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s10067-018-4122-2","volume":"37","author":"H So","year":"2018","unstructured":"So H, Wong VTL, Lao VWN, Pang HT, Yip RML (2018) Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis (in eng). Clin Rheumatol 37(7):1983\u20131989. https:\/\/doi.org\/10.1007\/s10067-018-4122-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5149_CR21","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y et al (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases (in eng). Neurology 95(1):e70\u2013e78. https:\/\/doi.org\/10.1212\/WNL.0000000000009727","journal-title":"Neurology"},{"issue":"10","key":"5149_CR22","first-page":"002860","volume":"8","author":"G Borio","year":"2021","unstructured":"Borio G et al (2021) Skin rash and interstitial pneumonia can be a fatal combination: a rare case of anti-melanoma differentiation-associated gene 5 (MDA5)-associated interstitial lung disease (in eng). Eur J Case Rep Intern Med 8(10):002860","journal-title":"Eur J Case Rep Intern Med"},{"key":"5149_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04897-1","author":"SK Dunga","year":"2021","unstructured":"Dunga SK, Kavadichanda C, Gupta L, Naveen R, Agarwal V, Negi VS (2021) Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study (in eng). Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-04897-1","journal-title":"Rheumatol Int"},{"issue":"1","key":"5149_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.semarthrit.2020.10.014","volume":"51","author":"L Gupta","year":"2021","unstructured":"Gupta L, Naveen R, Gaur P, Agarwal V, Aggarwal R (2021) Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis (in eng). Semin Arthritis Rheum 51(1):113\u2013120. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.014","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"5149_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jdcr.2020.07.019","volume":"6","author":"L Chen","year":"2020","unstructured":"Chen L, Owens K, Murina A (2020) Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema. JAAD Case Rep 6(9):909\u2013911. https:\/\/doi.org\/10.1016\/j.jdcr.2020.07.019","journal-title":"JAAD Case Rep"},{"key":"5149_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.rmcr.2019.01.012","volume":"26","author":"J Aoyama","year":"2019","unstructured":"Aoyama J et al (2019) Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations. Respir Med Case Rep 26:193\u2013196. https:\/\/doi.org\/10.1016\/j.rmcr.2019.01.012","journal-title":"Respir Med Case Rep"},{"key":"5149_CR27","doi-asserted-by":"publisher","first-page":"740154","DOI":"10.3389\/fmed.2021.740154","volume":"8","author":"L Huang","year":"2021","unstructured":"Huang L et al (2021) Association of cytomegalovirus infection with anti-MDA5 Antibody-positive dermatomyositis: a prospective cohort study (in eng). Front Med (Lausanne) 8:740154. https:\/\/doi.org\/10.3389\/fmed.2021.740154","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"5149_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/annrheumdis-2020-217522","volume":"77","author":"S Megremis","year":"2020","unstructured":"Megremis S et al (2020) Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis 77(10):1383\u20131386. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217522","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5149_CR29","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamaneurol.2021.2004","volume":"78","author":"T Aschman","year":"2021","unstructured":"Aschman T et al (2021) Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died (in eng). JAMA Neurol 78(8):948\u2013960. https:\/\/doi.org\/10.1001\/jamaneurol.2021.2004","journal-title":"JAMA Neurol"},{"issue":"1","key":"5149_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12890-020-01335-z","volume":"20","author":"M Cao","year":"2020","unstructured":"Cao M et al (2020) COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report (in eng). BMC Pulm Med 20(1):304. https:\/\/doi.org\/10.1186\/s12890-020-01335-z","journal-title":"BMC Pulm Med"},{"key":"5149_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791348","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G et al (2021) Presence of Anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study (in eng). Front Immunol 12:791348. https:\/\/doi.org\/10.3389\/fimmu.2021.791348","journal-title":"Front Immunol"},{"issue":"8","key":"5149_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M et al (2020) Covid-19 and autoimmunity (in eng). Autoimmun Rev 19(8):102597. https:\/\/doi.org\/10.1016\/j.autrev.2020.102597","journal-title":"Autoimmun Rev"},{"key":"5149_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102506","volume":"114","author":"Y Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez Y et al (2020) Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 (in eng). J Autoimmun 114:102506. https:\/\/doi.org\/10.1016\/j.jaut.2020.102506","journal-title":"J Autoimmun"},{"key":"5149_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.29.20164780","author":"C Liu","year":"2020","unstructured":"Liu C et al (2020) Analysis of the correlation between anti-MDA5 antibody and the severity of COVID-19: a retrospective study. medRxiv. https:\/\/doi.org\/10.1101\/2020.07.29.20164780","journal-title":"medRxiv"},{"key":"5149_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747116","volume":"12","author":"J Qian","year":"2021","unstructured":"Qian J, Xu H (2021) COVID-19 disease and dermatomyositis: a mini-review (in eng). Front Immunol 12:747116. https:\/\/doi.org\/10.3389\/fimmu.2021.747116","journal-title":"Front Immunol"},{"issue":"15","key":"5149_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01091-0","volume":"40","author":"LG Thorne","year":"2021","unstructured":"Thorne LG et al (2021) SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. Embo J 40(15):e107826. https:\/\/doi.org\/10.1038\/s41590-021-01091-0","journal-title":"Embo J"},{"issue":"1","key":"5149_CR37","doi-asserted-by":"publisher","first-page":"13638","DOI":"10.1038\/s41598-021-92940-3","volume":"11","author":"NG Sampaio","year":"2021","unstructured":"Sampaio NG et al (2021) The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci Rep 11(1):13638. https:\/\/doi.org\/10.1038\/s41598-021-92940-3","journal-title":"Sci Rep"},{"issue":"1","key":"5149_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior AG, Sampaio NG, Rehwinkel J (2019) A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol 27(1):75\u201385. https:\/\/doi.org\/10.1016\/j.tim.2018.08.007","journal-title":"Trends Microbiol"},{"issue":"2","key":"5149_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1189\/jlb.4MR0617-223R","volume":"103","author":"AJ Sadler","year":"2018","unstructured":"Sadler AJ (2018) The role of MDA5 in the development of autoimmune disease. J Leukoc Biol 103(2):185\u2013192. https:\/\/doi.org\/10.1189\/jlb.4MR0617-223R","journal-title":"J Leukoc Biol"},{"issue":"5","key":"5149_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso F et al (2020) Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? (in eng). Autoimmun Rev 19(5):102524. https:\/\/doi.org\/10.1016\/j.autrev.2020.102524","journal-title":"Autoimmun Rev"},{"issue":"6","key":"5149_CR41","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3547","volume":"13","author":"Y Muro","year":"2011","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K (2011) Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan (in eng). Arthritis Res Ther 13(6):R214. https:\/\/doi.org\/10.1186\/ar3547","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5149_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41564-021-00884-1","volume":"6","author":"G Liu","year":"2021","unstructured":"Liu G et al (2021) ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity (in eng). Nat Microbiol 6(4):467\u2013478. https:\/\/doi.org\/10.1038\/s41564-021-00884-1","journal-title":"Nat Microbiol"},{"key":"5149_CR43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3389\/fimmu.2020.00939","volume":"11","author":"H Fischer","year":"2020","unstructured":"Fischer H, Tschachler E, Eckhart L (2020) Pangolins lack IFIH1\/MDA5, a cytoplasmic RNA sensor that initiates innate immune defense upon Coronavirus infection (in eng). Front Immunol 11:939. https:\/\/doi.org\/10.3389\/fimmu.2020.00939","journal-title":"Front Immunol"},{"issue":"4","key":"5149_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejr.2021.06.001","volume":"43","author":"P Gupta","year":"2021","unstructured":"Gupta P, Kharbanda R, Lawrence A, Gupta L (2021) Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic. The Egyptian Rheumatologist 43(4):271\u2013274. https:\/\/doi.org\/10.1016\/j.ejr.2021.06.001","journal-title":"The Egyptian Rheumatologist"},{"issue":"7","key":"5149_CR45","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1093\/rheumatology\/keaa821","volume":"60","author":"U Rathore","year":"2021","unstructured":"Rathore U, Haldule S, Gupta L (2021) Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis (in eng). Rheumatology (Oxford) 60(7):3483. https:\/\/doi.org\/10.1093\/rheumatology\/keaa821","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5149_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges (in eng). Nat Rev Immunol 21(4):195\u2013197. https:\/\/doi.org\/10.1038\/s41577-021-00526-x","journal-title":"Nat Rev Immunol"},{"key":"5149_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108665","volume":"224","author":"R Talotta","year":"2021","unstructured":"Talotta R (2021) Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\u201d (in eng). Clin Immunol 224:108665. https:\/\/doi.org\/10.1016\/j.clim.2021.108665","journal-title":"Clin Immunol"},{"key":"5149_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases (in eng). Clin Immunol 217:108480. https:\/\/doi.org\/10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"issue":"Suppl 1","key":"5149_CR49","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jcpa.2007.04.013","volume":"137","author":"S Goriely","year":"2007","unstructured":"Goriely S, Goldman M (2007) From tolerance to autoimmunity: is there a risk in early life vaccination? (in eng). J Comp Pathol 137(Suppl 1):S57-61. https:\/\/doi.org\/10.1016\/j.jcpa.2007.04.013","journal-title":"J Comp Pathol"},{"issue":"12","key":"5149_CR50","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups (in eng). Ann Rheum Dis 76(12):1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5149_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/qjmed\/hcab043","volume":"114","author":"DJ Theodorou","year":"2021","unstructured":"Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N (2021) COVID-19 vaccine-related myositis (in eng). QJM 114(6):424\u2013425. https:\/\/doi.org\/10.1093\/qjmed\/hcab043","journal-title":"QJM"},{"issue":"12","key":"5149_CR52","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3949\/ccjm.88a.21038","volume":"88","author":"S Ramalingam","year":"2021","unstructured":"Ramalingam S et al (2021) COVID-19 vaccine-induced cellulitis and myositis (in eng). Cleve Clin J Med 88(12):648\u2013650. https:\/\/doi.org\/10.3949\/ccjm.88a.21038","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"5149_CR53","doi-asserted-by":"publisher","first-page":"e747","DOI":"10.1016\/S2665-9913(21)00312-X","volume":"3","author":"BV Maramattom","year":"2021","unstructured":"Maramattom BV, Philips G, Thomas J, Santhamma SGN (2021) Inflammatory myositis after ChAdOx1 vaccination (in eng). Lancet Rheumatol 3(11):e747\u2013e749. https:\/\/doi.org\/10.1016\/S2665-9913(21)00312-X","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"5149_CR54","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1002\/jmv.27175","volume":"93","author":"M Capassoni","year":"2021","unstructured":"Capassoni M et al (2021) AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: a case report. J Med Virol 93(10):5718\u20135720. https:\/\/doi.org\/10.1002\/jmv.27175","journal-title":"J Med Virol"},{"key":"5149_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15147","author":"LD Kaulen","year":"2021","unstructured":"Kaulen LD et al (2021) Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series (in eng). Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.15147","journal-title":"Eur J Neurol"},{"issue":"6","key":"5149_CR56","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5114\/reum.2021.111836","volume":"59","author":"K Gupta","year":"2021","unstructured":"Gupta K, Sharma GS, Kumar A (2021) COVID-19 vaccination-associated anti-Jo-1 syndrome (in eng). Reumatologia 59(6):420\u2013422. https:\/\/doi.org\/10.5114\/reum.2021.111836","journal-title":"Reumatologia"},{"issue":"5","key":"5149_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis (in eng). Nat Rev Rheumatol 14(5):290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5149_CR58","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bpa.12844","volume":"30","author":"M Duchesne","year":"2020","unstructured":"Duchesne M et al (2020) Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis (in eng). Brain Pathol 30(5):867\u2013876. https:\/\/doi.org\/10.1111\/bpa.12844","journal-title":"Brain Pathol"},{"issue":"2","key":"5149_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semarthrit.2014.04.004","volume":"44","author":"JC Milisenda","year":"2014","unstructured":"Milisenda JC, Doti PI, Prieto-Gonz\u00e1lez S, Grau JM (2014) Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature (in eng). Semin Arthritis Rheum 44(2):228\u2013233. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.04.004","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"5149_CR60","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.19723\/j.issn.1671-167X.2020.06.016","volume":"52","author":"YM Zheng","year":"2020","unstructured":"Zheng YM et al (2020) Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies (in chi). Beijing Da Xue Xue Bao Yi Xue Ban 52(6):1088\u20131092. https:\/\/doi.org\/10.19723\/j.issn.1671-167X.2020.06.016","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05149-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:04:50Z","timestamp":1659499490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05149-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,4]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5149"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05149-6","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,4]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All co-authors are familiar with the revised, final version of the work and take full responsibility for the integrity and accuracy of all aspects of the work. No part of the manuscript, including photographs, has been copied or published elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}